Sumitomo Pharma Co (TSE:4506) Cyclically Adjusted FCF per Share: 円34.53 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4506 Sumitomo Pharma Co Ltd TSE:4506
64 GF Score
Price 円1,266.00
GF Value 円843.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sumitomo Pharma Co Cyclically Adjusted FCF per Share?

Sumitomo Pharma Co TSE:4506 -2.05% 64 Cyclically Adjusted FCF per Share is 円34.53 as of Mar. 2026. GuruFocus rates TSE:4506 with a GF Score™ of 64/100 and a GF Value™ of 円843.41 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was 円70.460. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is 円34.53 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sumitomo Pharma Co's average Cyclically Adjusted FCF Growth Rate was 88.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -35.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -37.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sumitomo Pharma Co was 11.10% per year. The lowest was -52.10% per year. And the median was -17.35% per year.

As of today (2026-07-29), Sumitomo Pharma Co's current stock price is 円1266.00. Sumitomo Pharma Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was 円34.53. Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF of today is 36.66.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sumitomo Pharma Co was 126.80. The lowest was 5.01. And the median was 15.40.


Sumitomo Pharma Co  (TSE:4506) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1266.00/34.53
=36.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sumitomo Pharma Co was 126.80. The lowest was 5.01. And the median was 15.40.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sumitomo Pharma Co Cyclically Adjusted FCF per Share Related Terms


Sumitomo Pharma Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co Cyclically Adjusted FCF per Share Chart

Sumitomo Pharma Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 149.20 128.26 19.09 18.31 34.53

Sumitomo Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.31 17.05 21.53 27.54 34.53

TSE:4506 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF falls into.


TSE:4506
64GF Score
Sumitomo Pharma Co Ltd TSE:4506
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sumitomo Pharma Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sumitomo Pharma Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=70.46/112.7000*112.7000
=70.460

Current CPI (Mar. 2026) = 112.7000.

Sumitomo Pharma Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 98.100 0.000
201609 0.000 98.000 0.000
201612 0.000 98.400 0.000
201703 0.000 98.100 0.000
201706 43.708 98.500 50.009
201709 39.396 98.800 44.939
201712 30.529 99.400 34.614
201803 90.410 99.200 102.714
201806 -29.389 99.200 -33.389
201809 28.065 99.900 31.661
201812 23.079 99.700 26.088
201903 68.347 99.700 77.259
201906 12.864 99.800 14.527
201909 46.338 100.100 52.171
201912 8.598 100.500 9.642
202003 14.699 100.300 16.516
202006 -3.189 99.900 -3.598
202009 56.507 99.900 63.747
202012 197.088 99.300 223.684
202103 63.706 99.900 71.869
202106 -90.009 99.500 -101.950
202109 -0.116 100.100 -0.131
202112 86.022 100.100 96.850
202203 48.768 101.100 54.364
202206 23.232 101.800 25.720
202209 37.073 103.100 40.525
202212 58.212 104.100 63.021
202303 -120.543 104.400 -130.126
202306 -338.382 105.200 -362.506
202309 -122.077 106.200 -129.549
202312 -147.718 106.800 -155.878
202403 -40.273 107.200 -42.339
202406 -72.247 108.200 -75.252
202409 62.919 108.900 65.115
202412 -4.269 110.700 -4.346
202503 22.339 111.100 22.661
202506 -6.653 111.700 -6.713
202509 41.929 112.000 42.191
202512 56.370 113.000 56.220
202603 70.460 112.700 70.460

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of 円34.53 mean?
Sumitomo Pharma Co (TSE:4506) has a Cyclically Adjusted FCF per Share of 円34.53 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors.
Is Sumitomo Pharma Co's Cyclically Adjusted FCF per Share too high?
Sumitomo Pharma Co's current Cyclically Adjusted FCF per Share is 円34.53. Overall, Sumitomo Pharma Co has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's Cyclically Adjusted FCF per Share compare to ZTS?
Sumitomo Pharma Co's Cyclically Adjusted FCF per Share of 円34.53 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Sumitomo Pharma Co and its competitors. Sumitomo Pharma Co's current Cyclically Adjusted FCF per Share is 円34.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (TSE:4506) is currently considered Significantly Overvalued. The stock's GF Value™ is 円843.41, compared to a current price of 円1,266.00 — trading 50.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is 円34.53. Sumitomo Pharma Co's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Sumitomo Pharma Co (TSE:4506), the current Cyclically Adjusted FCF per Share is 円34.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sumitomo Pharma Co (TSE:4506) Overvalued in 2026?

Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued. The current stock price of 円1,266.00 is trading 50.1% above its estimated GF Value™ of 円843.41. GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.

Key valuation signals for TSE:4506:

  • Cyclically Adjusted FCF per Share: 円34.53
  • GF Value™: 円843.41 vs. price of 円1,266.00 (50.1% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the TSE:4506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sumitomo Pharma Co Business Description

Address 6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
64GF Score

Get the complete analysis for TSE:4506

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,266.00
Price
円843.41
GF Value